ONS-5010 is an investigational ophthalmic formulation of bevacizumab, a vascular endothelial growth factor inhibitor (VEGF), under development as an intravitreal injection ... enrolled an estimated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback